Zerion News

May 10, 2021

ZERION PHARMA elects Dr. Torsten Goesch and Dr. Lars Lykke Thomsen as new board members

(Copenhagen, May 10, 2021). ZERION Pharma, a Danish pharmaceutical company, elected two new members Dr. Torsten Goesch and Dr. Lars Lykke Thomsen to join its board of directors at the annual general meeting held...

April 8, 2021

Zerion Team in Numbers

An international and very diverse team is behind Zerion Pharma – a drug development company improving the formulation of poorly soluble drugs that are currently not reaching their therapeutical potential...

March 12, 2021

ZERION Pharma expands its team with a Communications Specialist and a Formulation Technician

Ieva Jasiukenaite is joining ZERION’s commercial team as a Communications Specialist and Camila Belavi is joining ZERION’s R&D team as a Laboratory Technician. Both already joined ZERION during February and March...

February 9, 2021

Arla Foods Ingredients and ZERION announce agreement to secure supply of Lacprodan® BLG as key component in ZERION’s Dispersome® technology

(Copenhagen, February 9, 2021). Arla Foods Ingredients Group P/S (Arla), a subsidiary of Arla Foods amba, and drug formulation company Zerion ApS (ZERION) have entered into an agreement covering the supply of...

January 4, 2021

ZERION expands its R&D team with Analytical Scientist and Scientific Director of Formulation to strengthen the company’s pipeline activities

Dr. Anis Arnous and Dr. Søren Vinter Søgaard will join ZERION’s R&D team as Analytical Scientist and Scientific Director...

November 12, 2020

ZERION appoints experienced CMC Director to join management team and drive the company’s drug development programs

PRESS RELEASE FOR IMMEDIATE RELEASE (Copenhagen, November 12, 2020). Danish drug formulation company ZERION announces the...

Zerion Pharma in Press